TW577889B - Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity - Google Patents

Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity Download PDF

Info

Publication number
TW577889B
TW577889B TW088121089A TW88121089A TW577889B TW 577889 B TW577889 B TW 577889B TW 088121089 A TW088121089 A TW 088121089A TW 88121089 A TW88121089 A TW 88121089A TW 577889 B TW577889 B TW 577889B
Authority
TW
Taiwan
Prior art keywords
methyl
pyridine
chloro
lhf
imidazo
Prior art date
Application number
TW088121089A
Other languages
English (en)
Chinese (zh)
Inventor
Hiroshi Kayakiri
Yoshito Abe
Hitoshi Hamashima
Hitoshi Sawada
Naoki Ishibashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW577889B publication Critical patent/TW577889B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW088121089A 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity TW577889B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34617598 1998-12-04
JP36754098 1998-12-24
JP25928399 1999-08-09

Publications (1)

Publication Number Publication Date
TW577889B true TW577889B (en) 2004-03-01

Family

ID=27334802

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088121089A TW577889B (en) 1998-12-04 1999-12-02 Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity

Country Status (15)

Country Link
US (2) US6573274B1 (cs)
EP (1) EP1136492A4 (cs)
KR (1) KR20010086593A (cs)
CN (1) CN1335847A (cs)
AR (1) AR021542A1 (cs)
AU (1) AU769890B2 (cs)
BR (1) BR9916919A (cs)
CA (1) CA2352871A1 (cs)
CZ (1) CZ20011981A3 (cs)
HK (1) HK1044154A1 (cs)
HU (1) HUP0104549A3 (cs)
IL (1) IL143439A0 (cs)
TR (1) TR200101568T2 (cs)
TW (1) TW577889B (cs)
WO (1) WO2000034277A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295239A1 (en) * 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
WO2002013798A2 (en) * 2000-08-11 2002-02-21 Pfizer Limited Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US20050197376A1 (en) * 2004-03-02 2005-09-08 Fujisawa Pharmaceutical Co. Ltd. Concomitant drugs
EP2114856A1 (en) * 2007-02-06 2009-11-11 Cipla Limited Process for the preparation of ethyl-n-(2, 3-dichloro-6-nitrobenzyl) glycine hydrochloride
WO2014123203A1 (ja) * 2013-02-06 2014-08-14 京都薬品工業株式会社 糖尿病治療薬
GB201321741D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
US9067914B1 (en) * 2013-12-10 2015-06-30 Genzyme Corporation Tropomyosin-related kinase (TRK) inhibitors
SMT202200134T1 (it) 2018-03-08 2022-05-12 Incyte Corp Composti di amminopirazindiolo come inibitori di pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215994A (en) * 1990-09-25 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic derivatives
EP0503838A3 (en) * 1991-03-08 1992-10-07 Merck & Co. Inc. Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
US5128327A (en) 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
WO1993019067A1 (en) 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
ES2244979T3 (es) 1995-12-28 2005-12-16 Fujisawa Pharmaceutical Co., Ltd. Derivados de benzimidazol.
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
DE69826286T2 (de) 1997-06-27 2005-11-24 Fujisawa Pharmaceutical Co., Ltd. Derivate mit einem aromatischen ring

Also Published As

Publication number Publication date
CN1335847A (zh) 2002-02-13
WO2000034277A1 (en) 2000-06-15
US6573274B1 (en) 2003-06-03
AU769890B2 (en) 2004-02-05
TR200101568T2 (tr) 2001-10-22
CA2352871A1 (en) 2000-06-15
CZ20011981A3 (cs) 2002-01-16
HUP0104549A3 (en) 2002-12-28
AR021542A1 (es) 2002-07-24
HUP0104549A2 (hu) 2002-04-29
AU1414100A (en) 2000-06-26
BR9916919A (pt) 2002-01-15
EP1136492A1 (en) 2001-09-26
KR20010086593A (ko) 2001-09-13
HK1044154A1 (zh) 2002-10-11
US20030171396A1 (en) 2003-09-11
EP1136492A4 (en) 2002-03-27
IL143439A0 (en) 2002-04-21
US6890934B2 (en) 2005-05-10

Similar Documents

Publication Publication Date Title
AU2021232806B2 (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
AU2006302135B2 (en) Kinase inhibitors
TWI567066B (zh) 蛋白質激酶抑制劑
AU774262B2 (en) Substituted pyrazoles as p38 kinase inhibitors
JP6356782B2 (ja) タンパク質キナーゼ阻害剤
EP1812439B1 (en) Kinase inhibitors
CN105732614B (zh) 磺酰胺基芳基炔类化合物及其用途
AU2014241152A1 (en) Benzimidazolone derivatives as bromodomain inhibitors
US20080153869A1 (en) Kinase Inhibitors
OA12058A (en) 5-(2-Substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazoloÄ4,3-DÜpyrimidin-7-ones as phosphodiesterase inhibitors.
ES2750791T3 (es) Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas
CA2887203A1 (en) 2,3-(hetero)aryl substituted pyridinyl compounds and their use as gdf-8 inhibitors
AU2012308570A1 (en) Indazole-3-carboxamides and their use as Wnt/b-catenin signaling pathway inhibitors
TW577889B (en) Sulfonamide compound having hypoglycemic activity or PDE-V inhibitory activity
CA2758958A1 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
KR20170098324A (ko) 특정 트리아졸로피리딘 및 트리아졸로피라진, 이들의 조성물 및 이들의 사용 방법
EP4168401B1 (en) Sulphonamide compounds
TW201144309A (en) Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
CN105906621A (zh) 用作fgfr抑制剂的乙醇类化合物
CA2908824A1 (en) Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereof
CN102887867B (zh) 一类三嗪类化合物、该化合物的制备方法及其用途
CN116655626B (zh) 一种含咪唑并[l,2-a]吡啶骨架的环丙二酰胺化合物及其制备方法和用途
HK40110743A (zh) 腺苷受体拮抗剂
JP2026021463A (ja) スルホンアミド化合物
MXPA01005374A (en) Sulfonamide compounds and uses thereof as medicines

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees